| Financial Year |
March 31 2023 |
| Monetary Funds |
367,495,000.38 |
| Held-for-trading Financial Assets |
405,549,287.67 |
| Notes Receivable |
138,225,947.00 |
| Accounts Receivable |
365,502,169.55 |
| Advances to Suppliers |
160,405,324.80 |
| Other Receivables |
12,855,496.93 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,335,321,852.19 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
-- |
| Total Current Assets |
2,966,091,810.02 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
141,746,003.37 |
| Under-construction Projects |
32,869,174.75 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
58,432,969.01 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,768,115.18 |
| Deferred Income Tax Assets |
21,554,364.45 |
| Other Non-Current Assets |
1,304,061.00 |
| Sub-Total of Non-Current Assets |
257,674,687.76 |
| Total Assets |
3,223,766,497.78 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
269,635,269.35 |
| Accounts Payable |
267,694,258.17 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
7,915,989.16 |
| Taxes Payable |
11,431,885.83 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,744,396.49 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
12,967,353.44 |
| Sub-Total of Current Liabilities |
1,428,900,213.68 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
7,955,212.01 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
36,371,933.12 |
| Total Liabilities |
1,465,272,146.80 |
| Paid-In Capital(Or Share Stock) |
133,340,000.00 |
| Capital Surplus |
1,009,389,695.94 |
| Surplus Reserve |
56,979,458.55 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
554,458,298.71 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,758,494,350.98 |
| Owner's Equity（Stockholder's Equity） |
1,758,494,350.98 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,223,766,497.78 |
